Table 1 Clinical characteristics of males and females in cerebral infarction patients and control participants

No. of subjects

938

1028

581

622

357

406

Age, y

65.5 ± 10.6

63.7 ± 12.4

63.9 ± 9.9

62.9 ± 12.6

68.3 ± 11.2

64.8 ± 12.1

< 0.001

Smokers, n(%)

258 (27.5%)

224 (21.8%)

256 (44.1%)

224 (36.0%)

2 (0.6%)

0 (0)

0.219

Alcohol, n(%)

40 (4.3%)

39 (3.8%)

40 (6.9%)

39 (6.3%)

0 (0)

0 (0)

–

Hypertension, n(%)

663 (70.7%)

505 (49.1%)

406 (69.9%)

287 (46.1%)

257 (72.0%)

218 (53.7%)

< 0.001

TG, mmol/L

2.145 ± 2.388

1.798 ± 1.443

2.128 ± 2.560

1.800 ± 1.608

2.171 ± 2.101

1.795 ± 1.126

0.003

TC, mmol/L

5.114 ± 1.398

5.047 ± 1.281

4.967 ± 1.280

5.009 ± 1.450

5.276 ± 1.299

5.178 ± 1.273

0.294

HDL-C, mmol/L

1.279 ± 0.373

1.271 ± 0.330

1.231 ± 0.358

1.219 ± 0.293

1.355 ± 0.368

1.352 ± 0.384

0.907

LDL-C, mmol/L

2.924 ± 0.902

2.864 ± 0.948

2.902 ± 0.909

2.836 ± 0.957

2.959 ± 0.890

2.908 ± 0.935

0.441

Apo-A1, g/L

1.142 ± 0.291

1.153 ± 0.333

1.096 ± 0.260

1.098 ± 0.299

1.215 ± 0.322

1.237 ± 0.364

0.396

Apo-B, g/L

0.904 ± 0.266

0.903 ± 0.298

0.899 ± 0.268

0.890 ± 0.302

0.912 ± 0.264

0.922 ± 0.292

0.631

Apo-A1/ Apo-B

1.359 ± 0.512

1.404 ± 0.611

1.316 ± 0.498

1.370 ± 0.626

1.429 ± 0.527

1.455 ± 0.584

0.514